Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd R Burmester

Showing results (21-30 of 334) with videos related to

Pageof 34
Sort By:
Current Opinion in Rheumatology|April 5, 2008
New approaches of B-cell-directed therapy: beyond rituximabThomas Dörner, Gerd R Burmester
Rheumatology (Oxford, England)|February 5, 2013
Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritisEugen Feist, Gerd R Burmester
Current Opinion in Rheumatology|April 29, 2009
Co-evolution of new immunotherapeutics and anti-infective strategiesThomas Dörner, Gerd R Burmester
Annals of the Rheumatic Diseases|July 3, 2020
Methotrexate: what are the true risks of treatment?Anja Strangfeld, Gerd R Burmester
RMD Open|May 5, 2023
Axial psoratic arthritis: are you a lumper or a splitter?Laura C Coates, Gerd R Burmester
Annals of the Rheumatic Diseases|June 13, 2020
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDsJohn D Isaacs, Gerd R Burmester
European Journal of Immunology|August 13, 2009
A clinical perspective of rheumatoid arthritisHans Ulrich Scherer, Gerd R Burmester
Lancet (London, England)|June 15, 2017
Novel treatment strategies in rheumatoid arthritisGerd R Burmester, Janet E Pope
Nature Reviews. Rheumatology|November 13, 2013
Emerging cell and cytokine targets in rheumatoid arthritisGerd R Burmester, Eugen Feist, Thomas Dörner
Annals of the Rheumatic Diseases|June 13, 2020
Digital crowdsourcing: unleashing its power in rheumatologyMartin Krusche, Gerd R Burmester, Johannes Knitza
Pageof 34

Showing results (21-30 of 334) with videos related to

Sort By:
Pageof 34
Current Opinion in Rheumatology|April 5, 2008
New approaches of B-cell-directed therapy: beyond rituximabThomas Dörner, Gerd R Burmester
Rheumatology (Oxford, England)|February 5, 2013
Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritisEugen Feist, Gerd R Burmester
Current Opinion in Rheumatology|April 29, 2009
Co-evolution of new immunotherapeutics and anti-infective strategiesThomas Dörner, Gerd R Burmester
Annals of the Rheumatic Diseases|July 3, 2020
Methotrexate: what are the true risks of treatment?Anja Strangfeld, Gerd R Burmester
RMD Open|May 5, 2023
Axial psoratic arthritis: are you a lumper or a splitter?Laura C Coates, Gerd R Burmester
Annals of the Rheumatic Diseases|June 13, 2020
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDsJohn D Isaacs, Gerd R Burmester
European Journal of Immunology|August 13, 2009
A clinical perspective of rheumatoid arthritisHans Ulrich Scherer, Gerd R Burmester
Lancet (London, England)|June 15, 2017
Novel treatment strategies in rheumatoid arthritisGerd R Burmester, Janet E Pope
Nature Reviews. Rheumatology|November 13, 2013
Emerging cell and cytokine targets in rheumatoid arthritisGerd R Burmester, Eugen Feist, Thomas Dörner
Annals of the Rheumatic Diseases|June 13, 2020
Digital crowdsourcing: unleashing its power in rheumatologyMartin Krusche, Gerd R Burmester, Johannes Knitza
Pageof 34